(Q37813414)

23 August 2017

1 reference

title

Immune monitoring and biomarkers to predict chronic allograft dysfunction (English)

1 reference

23 August 2017

0 references

immunologic monitoring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21116320

4 September 2024

1

Roslyn B. Mannon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21116320

4 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21116320

4 September 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

http://www.kidney-international.org/article/S0085253815544827/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21116320

https://api.elsevier.com/content/article/PII:S0085253815544827?httpAccept=text/xml

4 September 2024

1 reference

https://api.elsevier.com/content/article/PII:S0085253815544827?httpAccept=text/plain

4 September 2024

1 reference

Kidney International. Supplement

4 September 2024

published in

1 reference

23 August 2017

issue

119

1 reference

23 August 2017

page(s)

S59-65

1 reference

The Banff 97 working classification of renal allograft pathology

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Call for revolution: a new approach to describing allograft deterioration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Fibrosis and atrophy in the renal allograft: interim report and new directions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Identifying specific causes of kidney allograft loss.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

The natural history of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Antibody-mediated organ-allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Predicting subsequent decline in kidney allograft function from early surveillance biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Noninvasive methods to assess the risk of kidney transplant rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Beyond histology: novel tools to diagnose allograft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Therapeutic targets in the treatment of allograft fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Predicting kidney graft failure by HLA antibodies: a prospective trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Rituximab and intravenous immune globulin for desensitization during renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Abrogation of anti-HLA antibodies via proteasome inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

T-cell immune monitoring in organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Bioinformatic analysis of the urine proteome of acute allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Urine proteomics to detect biomarkers for chronic allograft dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Calcineurin inhibitors and proximal renal tubular injury in renal transplant patients with proteinuria and chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Functionally significant renal allograft rejection is defined by transcriptional criteria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Molecular evaluation of BK polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

The significance of subclinical rejection and the value of protocol biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.425

7 January 2021

Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study

series ordinal

8

1 reference

Anti-HLA class II antibodies and chronic allograft nephropathy

4 September 2024

series ordinal

22

1 reference

Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis

4 September 2024

series ordinal

47

1 reference

4 September 2024

Identifiers

DOI

10.1038/KI.2010.425

1 reference

23 August 2017

1 reference